1. |
Patterson TF, Thompson GR, Denning DW, et al. Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2016, 63(4): 433-442.
|
2. |
Wu N, Huang Y, Li Q, et al. Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases. Clin Microbiol Infect, 2010, 16(6): 689-695.
|
3. |
Temime J, Mallat J, Van Grunderbeeck N, et al. Fulminant invasive tracheobronchial aspergillosis. Am J Respir Crit Care Med, 2015, 191(7): 848-849.
|
4. |
Fernández-Ruiz M, Silva JT, San-Juan R, et al. Aspergillus tracheobronchitis: report of 8 cases and review of the literature. Medicine (Baltimore), 2012, 91(5): 261-273.
|
5. |
Hartemink KJ, Paul MA, Spijkstra JJ, et al. Immunoparalysis as a cause for invasive aspergillosis?. Intensive Care Med, 2003, 29(11): 2068-2071.
|
6. |
Ramos A, Segovia, J, Gomez-Bueno M, et al. Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient. Transpl Infect Dis, 2010, 12(1): 60-63.
|
7. |
Aliyali M, Hedayat MT, Habibi MR, et al. Clinical risk factors and bronchoscopic features of invasive aspergillosis in intensive care unit patients. J Prev Med Hyg, 2013, 54(2): 80-82.
|
8. |
De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis, 2008, 46(12): 1813-1821.
|